![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Lee Paul Hegele Robert A
Publisher: Informa Healthcare
ISSN: 1354-3784
Source: Expert Opinion on Investigational Drugs, Vol.22, Iss.11, 2013-11, pp. : 1411-1423
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Strategies for proprotein convertase subtilisin kexin 9 modulation: a perspective on recent patents
By Abifadel Marianne Pakradouni Jihane Collin Matthieu Samson-Bouma Marie-Elisabeth Varret Mathilde Rabès Jean-Pierre Boileau Catherine
Expert Opinion on Therapeutic Patents, Vol. 20, Iss. 11, 2010-11 ,pp. :